Genesis Therapeutics Revenue

Biotechnology Research • Burlingame, California, United States • 101-200 Employees

Genesis Therapeutics revenue & valuation

Annual revenue	$1,000,000
Revenue per employee	$8,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,200,000
Total funding	$200,000,000

Key Contacts at Genesis Therapeutics

Irene Hyo White

Head Of People, Sr. Director

Evan Feinberg

Founder And Ceo

Yoshihiro Ishihara

Associate Director

Alexander Goldberg

Director Of New Product Planning

Carl Tilbury

Senior Director, Business Development And Strategy

Andrew Flick

Director Of Chemistry

Advait Nagle

Sr.Director Med. Chem.

Frank Pickard

Director, Computational Chemistry Methods

Gerald Lelais

Executive Director Of Medicinal Chemistry

Matthew Mackenzie

Associate Director, Fp&A

Company overview

Headquarters	Burlingame, California, United States
Phone number	+12036154567
Website	genesistherapeutics.ai
NAICS	541714
Keywords	Drug Discovery, Artificial Intelligence, Deep Learning, Drug Development
Employees	101-200
Socials

Genesis Therapeutics Email Formats

Genesis Therapeutics uses 5 email formats. The most common is {first name} (e.g., john@genesistherapeutics.ai), used 71.9% of the time.

Format	Example	Percentage
{first name}	john@genesistherapeutics.ai	71.9%
{first initial}{last name}	jdoe@genesistherapeutics.ai	13.4%
{first name}{last name}	johndoe@genesistherapeutics.ai	11.2%
{first initial}.{last name}	j.doe@genesistherapeutics.ai	1.1%

About Genesis Therapeutics

Genesis Therapeutics – headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego – is unifying AI and biotechnology to discover novel and breakthrough treatments for patients with severe and devastating conditions. We are using a proprietary state-of-the-art generative and predictive AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery. The GEMS platform integrates deep learning-based predictive models, molecular simulations, and molecular generative AI. GEMS accelerates hit ID through lead optimization and candidate selection by generating promising molecules for synthesis and experimental testing, and iterating this process through multiple cycles of AI-enabled discovery and optimization. We have leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has two AI platform collaborations across a range of therapeutic areas: Eli Lilly (signed in 2022) and Genentech (signed in 2020). Genesis has raised over $280M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures. We are rapidly growing our team with a variety of openings on our machine learning, computational chemistry, and software teams (primarily located in the Bay Area) and our chemistry, biology, and clinical teams (primarily located in San Diego). To learn more about Genesis Therapeutics, or current employment opportunities, please visit our website.

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Entry

Director

Senior

Employees by Department

Genesis Therapeutics has 75 employees across 13 departments.

Departments

Number of employees

Funding Data

Explore Genesis Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-09-21	5	$200,000,000

Funding Insights

$200,000,000

Total funding amount

$200,000,000

Most recent funding amount

Number of funding rounds

Genesis Therapeutics Tech Stack

Discover the technologies and tools that power Genesis Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Element UI

UI frameworks

Cloudflare Bot Management

Security

Apollo

JavaScript libraries

Cloudflare

CDN

Apple iCloud Mail

Webmail

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Lenis

JavaScript libraries

Yoast SEO

SEO

Google Workspace

Frequently asked questions

Genesis Therapeutics is located in Burlingame, California, US.

You can reach Genesis Therapeutics at +12036154567.

Genesis Therapeutics generates an estimated annual revenue of $1,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Genesis Therapeutics has an estimated valuation of $3,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Genesis Therapeutics has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

Genesis Therapeutics has raised a total of $200,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.